Desoxyn is a prescription medication containing methamphetamine hydrochloride, and it is FDA-approved to treat attention deficit hyperactivity disorder (ADHD) in children ages 6 through 17. It also carries an older approval for short-term weight management in obesity. The name surprises many people because methamphetamine is far better known as an illegal street drug, but Desoxyn is a carefully dosed, pharmaceutical-grade form that has been on the market since the 1940s.
ADHD Treatment in Children
Desoxyn’s primary use today is treating ADHD in pediatric patients 6 years and older. The FDA label describes the target population as children with a behavioral pattern that includes moderate to severe distractibility, a short attention span, hyperactivity, emotional instability, and impulsivity. It is not approved for children under 6, and the label specifies that it should be part of a broader treatment program that includes psychological, educational, and social support rather than medication alone.
The starting dose is 5 mg taken once or twice a day. A prescriber can increase the dose by 5 mg each week based on how a child responds, with the typical effective range landing between 20 mg and 25 mg per day. These doses are far lower than what recreational users of illicit methamphetamine consume, which is one reason the medication can be therapeutic without producing the extreme highs associated with abuse.
In practice, Desoxyn is rarely the first medication tried for ADHD. Most clinicians start with more common stimulants like mixed amphetamine salts (Adderall) or methylphenidate (Ritalin, Concerta). Desoxyn tends to be reserved for patients who haven’t responded well to those options. It is not approved for narcolepsy, which is one practical difference from Adderall.
Short-Term Obesity Treatment
Desoxyn also has an FDA-approved indication for weight loss in people with obesity that hasn’t responded to other approaches like calorie restriction or exercise programs. For this use, the dose is a single 5 mg tablet taken half an hour before each meal. The FDA label is clear that this treatment “should not exceed a few weeks in duration,” making it a very short-term intervention rather than an ongoing weight management strategy.
This indication is a holdover from an era when amphetamine-class drugs were widely prescribed as appetite suppressants. Today, newer weight loss medications with better safety profiles have largely replaced stimulants for this purpose, so Desoxyn is seldom prescribed for obesity in modern practice.
How Desoxyn Works in the Brain
Desoxyn increases levels of three key chemical messengers in the brain: dopamine, norepinephrine, and serotonin. Rather than simply blocking their reabsorption the way some other medications do, methamphetamine actively pushes these chemicals out of nerve endings and into the spaces between neurons, where they can amplify signaling.
The process works in two steps. First, the drug moves stored neurotransmitters out of their storage compartments inside the nerve cell and into the cell’s main interior. Then it reverses the normal recycling mechanism on the cell surface so those neurotransmitters flow outward into the gap between neurons instead of being pulled back in. The result is a significant boost in dopamine and norepinephrine activity.
For someone with ADHD, this surge in dopamine improves focus, impulse control, and the ability to sustain attention. The norepinephrine increase also contributes to alertness. Outside the brain, norepinephrine release from nerve endings that control the heart and blood vessels explains why stimulants can raise heart rate and blood pressure, which is the basis for many of the medication’s cardiovascular side effects.
Side Effects and Risks
The side effects of Desoxyn overlap with those of other stimulant medications. Common ones include decreased appetite, trouble sleeping, dry mouth, headache, and stomach discomfort. Because the drug increases norepinephrine throughout the body, elevated heart rate and blood pressure are possible, and prescribers typically monitor cardiovascular health during treatment.
Psychiatric side effects can also occur. Some patients experience irritability, anxiety, or mood changes. In rare cases, stimulants can trigger new psychotic symptoms or worsen existing ones, particularly at higher doses. Growth suppression is another concern for children on long-term stimulant therapy, so height and weight are usually tracked at regular visits.
Why Desoxyn Is Tightly Controlled
Desoxyn is classified as a Schedule II controlled substance, the most restrictive category for medications that have an accepted medical use. This puts it in the same regulatory tier as oxycodone and fentanyl. In practical terms, that means you cannot get automatic refills. Each fill requires a new prescription, and the prescriber, pharmacy, and patient all face strict record-keeping requirements.
The scheduling reflects the high potential for misuse and physical dependence associated with methamphetamine. At therapeutic doses taken as prescribed, the risk profile is manageable and comparable to other stimulants. But the same chemical at higher doses or delivered through faster routes (smoking, injection) produces intense euphoria and carries severe addiction risk. This dual identity is the reason Desoxyn exists in a strange cultural space: a legitimate, FDA-approved medicine that shares its active ingredient with one of the most stigmatized street drugs.
How Desoxyn Compares to Other ADHD Medications
Desoxyn and Adderall are close chemical relatives. Adderall contains a mix of amphetamine salts, while Desoxyn contains methamphetamine, which is essentially amphetamine with one extra chemical group attached. That small structural difference allows methamphetamine to cross into the brain slightly more efficiently, which is why it can be effective at relatively low doses. Both medications work through the same general mechanism of boosting dopamine and norepinephrine, and both are Schedule II drugs.
The practical differences matter more than the chemistry. Adderall is available in both immediate-release and extended-release forms, while Desoxyn comes only as an immediate-release tablet. Adderall is also approved for narcolepsy, giving it a broader range of uses. And because Adderall has been far more widely studied and prescribed, most clinicians are more comfortable reaching for it first. Desoxyn fills a niche for the small number of patients who need an alternative after other stimulants have fallen short.
Methylphenidate-based medications like Ritalin and Concerta work differently at the molecular level. They primarily block the recycling of dopamine rather than forcing it out of nerve cells, which generally makes them somewhat milder. For many patients, that milder mechanism is enough. The progression from methylphenidate to amphetamine salts to methamphetamine reflects an escalation in potency that clinicians use only when less intense options have not produced adequate results.